AnalysisNews

VTAK today

$1.51-$0.01 (-0.66%)close Oct 2, 2026

Trend

—

Key levels

Resistance$8.50

Resistance$7.67

Support$1.45

Latest news & SEC filings

DealFlyte Aviation plans to sell off former Catheter Precision holdings

ProductCatheter Precision gains FDA 510(k) clearance for broader VIVO labeling

ProductCatheter Precision Reports Published Study Comparing LockeT Device

All VTAK news →

NYSE · Healthcare

Flyte Aviation, Inc. (VTAK)

$1.51-0.01 (-0.66%)
HOLDGrade: CRisk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
1.561.701.831.971.51Aug 31Sep 9Sep 17Sep 25
High1.58
Low1.48
Open1.53
Volume84K
Avg Vol85K
VWAP1.52
30d High2.10
30d Low1.43
30d Chg-27.85%

What Is the Price Target for VTAK?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $1.53Upside: +0.0%Confidence: 20%Method: No Coverage

Is VTAK a Buy or Sell Right Now?

44
Investability Score
HOLD12-18 months

Thesis

  • •Revenue growing 95.0% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VTAK.

Start Free Trial →

Is VTAK Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B, PEG

Fair Value

$102.94

37

Moat Score

NONE

3/9

Piotroski Score

-31.9

Altman Z-Score

What Is Smart Money Doing with VTAK?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

VTAK Growth Story

Revenue YoY

95.0%

3yr Revenue CAGR

N/A%

EPS Growth YoY

N/A

FCF Growth YoY

11.0%

Revenue Trend

ACCELERATING

Dark Pool Trades for VTAK

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for VTAK, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
23:29:47$0.161,000$$160BUY
23:22:42$0.1610,000$$2KBUY
23:02:03$0.1513,984$$2KSELL
22:39:49$0.161,000$$160BUY
22:27:35$0.169,900$$2KBUY

5 dark pool trades shown · $$6K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Flyte Aviation, Inc. (VTAK) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

VTAK — frequently asked questions

What is VTAK stock price today?

Flyte Aviation, Inc. (VTAK) is at $1.51, down 0.66% (-$0.01) at the Oct 2, 2026 close.

Why is VTAK stock moving today?

Latest VTAK news — Nov 5, 2026: Flyte Aviation plans to sell off former Catheter Precision holdings · Nov 3, 2026: Catheter Precision gains FDA 510(k) clearance for broader VIVO labeling

Did VTAK beat earnings?

VTAK last reported on Aug 14, 2026: EPS -$0.92 vs -$19.00 expected — a beat of 95.2%.

Does VTAK pay a dividend?

VTAK does not currently pay a dividend.

What are VTAK support and resistance levels?

Support: $1.45. Resistance: $7.67, $8.50, $10.50.

What are insiders doing with VTAK?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on VTAK?

Nov 5, 2026: Flyte Aviation plans to sell off former Catheter Precision holdings · Nov 3, 2026: Catheter Precision gains FDA 510(k) clearance for broader VIVO labeling · Oct 24, 2026: Catheter Precision Reports Published Study Comparing LockeT Device